Опыт применения помалидомида в комбинации с низкими дозами дексаметазона при множественной миеломе с «Двойной рефрактерностью»
А В Петров, А Ю Зарицкий, Д В Бабенецкая, Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Л Л Гиршова(Federal Almazov North-West Medical Research Centre), Е С Урнова, М В Нарейко(Endocrinology Research Center), Ю. А. Алексеева, О С Покровская, D.V. Motorin(Federal Almazov North-West Medical Research Centre)
Клиническая онкогематология. Фундаментальные исследования и клиническая практика
January 1, 2017
Cited by 0
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59